Literature DB >> 30408456

The effect of immediate postpartum levonorgestrel contraceptive implant use on breastfeeding and infant growth: a randomized controlled trial.

Sarah Averbach1, Othman Kakaire2, Rachel McDiehl3, Christine Dehlendorf4, Felicia Lester4, Jody Steinauer4.   

Abstract

OBJECTIVE: This study assessed whether immediate postpartum insertion of levonorgestrel contraceptive implants is associated with a difference in infant growth from birth to 6 months, onset of lactogenesis, or breastfeeding continuation at 3 and 6 months postpartum compared to delayed insertion at 6 to 8 weeks postpartum. STUDY
DESIGN: We conducted a randomized trial of women in Uganda who desired contraceptive implants postpartum. We randomly assigned participants to receive either immediate (within 5 days of delivery) or delayed (6 to 8 weeks postpartum) insertion of a two-rod levonorgestrel contraceptive implant system. This is a prespecified secondary analysis evaluating breastfeeding outcomes. The primary outcome of this secondary analysis was change in infant weight; infants were weighed and measured at birth and 6 months. We used a validated questionnaire to assess onset of lactogenesis daily in person while participants were in the hospital, and then daily by phone after they left the hospital, until lactogenesis was documented. We used interviewer-administered questionnaires to assess breastfeeding continuation and concerns at 3 months and 6 months postpartum.
RESULTS: Among the 96 women randomized to the immediate group and the 87 women to the delayed group, the mean change in infant weight from birth to 6 months was similar between groups: 4632 g in the immediate group and 4407 g in the delayed group (p=.26). Among the 97 women who had not experienced lactogenesis prior to randomization, the median time to onset of lactogenesis did not differ significantly between the immediate and delayed groups (65 h versus 63 h; p=.84). Similar proportions of women in the immediate and delayed groups reported exclusive breastfeeding at 3 months (74% versus 71%; p=.74) and 6 months (48% versus 52%; p=.58).
CONCLUSION: We found no association between the timing of postpartum initiation of levonorgestrel contraceptive implants and change in infant growth from birth to 6 months, onset of lactogenesis, or breastfeeding continuation at 3 or 6 months postpartum. IMPLICATIONS: This study provides evidence that immediate postpartum initiation of contraception implants does not have a deleterious effect on infant growth or initiation or continuation of breastfeeding.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Breastfeeding; Contraception; Implant; Lactogenesis, postpartum; Progestin

Year:  2018        PMID: 30408456      PMCID: PMC6419727          DOI: 10.1016/j.contraception.2018.10.008

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  25 in total

1.  Maternal perception of the onset of lactation is a valid, public health indicator of lactogenesis stage II.

Authors:  D J Chapman; R Pérez-Escamilla
Journal:  J Nutr       Date:  2000-12       Impact factor: 4.798

2.  Missed opportunities for family planning: an analysis of pregnancy risk and contraceptive method use among postpartum women in 21 low- and middle-income countries.

Authors:  Zhuzhi Moore; Anne Pfitzer; Rehana Gubin; Elaine Charurat; Leah Elliott; Trevor Croft
Journal:  Contraception       Date:  2015-03-11       Impact factor: 3.375

3.  Immediate postpartum levonorgestrel intrauterine device insertion and breast-feeding outcomes: a noninferiority randomized controlled trial.

Authors:  David K Turok; Lawrence Leeman; Jessica N Sanders; Lauren Thaxton; Jennifer L Eggebroten; Nicole Yonke; Holly Bullock; Rameet Singh; Lori M Gawron; Eve Espey
Journal:  Am J Obstet Gynecol       Date:  2017-08-23       Impact factor: 8.661

4.  Effect of hormonal contraceptives during breastfeeding on infant's milk ingestion and growth.

Authors:  Luis Bahamondes; M Valeria Bahamondes; Waleska Modesto; Ian B Tilley; Alviclér Magalhães; João Luiz Pinto e Silva; Eliana Amaral; Daniel R Mishell
Journal:  Fertil Steril       Date:  2013-04-23       Impact factor: 7.329

5.  Maternal morbidity and mortality associated with interpregnancy interval: cross sectional study.

Authors:  A Conde-Agudelo; J M Belizán
Journal:  BMJ       Date:  2000-11-18

6.  Effects of the etonogestrel-releasing contraceptive implant (Implanon on parameters of breastfeeding compared to those of an intrauterine device.

Authors:  D Reinprayoon; S Taneepanichskul; S Bunyavejchevin; P Thaithumyanon; S Punnahitananda; P Tosukhowong; C Machielsen; A van Beek
Journal:  Contraception       Date:  2000-11       Impact factor: 3.375

7.  Prevalence of low birth weight and preterm delivery in relation to the interval between pregnancies among white and black women.

Authors:  J S Rawlings; V B Rawlings; J A Read
Journal:  N Engl J Med       Date:  1995-01-12       Impact factor: 91.245

8.  Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study.

Authors:  Milena Bastos Brito; Rui Alberto Ferriani; Silvana Maria Quintana; Marta Edna Holanda Diogenes Yazlle; Marcos Felipe Silva de Sá; Carolina Sales Vieira
Journal:  Contraception       Date:  2009-07-10       Impact factor: 3.375

9.  Duration of breast-feeding and development of children after insertion of a levonorgestrel-releasing intrauterine contraceptive device.

Authors:  M Heikkilä; T Luukkainen
Journal:  Contraception       Date:  1982-03       Impact factor: 3.375

10.  Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks.

Authors:  Kimberly K Scarsi; Kristin M Darin; Shadia Nakalema; David J Back; Pauline Byakika-Kibwika; Laura J Else; Sujan Dilly Penchala; Allan Buzibye; Susan E Cohn; Concepta Merry; Mohammed Lamorde
Journal:  Clin Infect Dis       Date:  2015-12-08       Impact factor: 9.079

View more
  1 in total

1.  Effect of Postpartum Depo Medroxyprogesterone Acetate on Lactation in Mothers of Very Low-Birth-Weight Infants.

Authors:  Leslie A Parker; Sandra Sullivan; Nicole Cacho; Charlene Krueger; Martina Mueller
Journal:  Breastfeed Med       Date:  2021-04-28       Impact factor: 2.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.